Related Experiment Video

Updated: Aug 7, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

24.6K

lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the

Guo Yang1, Ting Li2, Jiayu Liu1

  • 1Department of Urology, The First Affiliated Hospital of Chongqing Medical University, 400042 Chongqing, China.

Genomics
|March 8, 2023
PubMed

Insights

MAGI2-AS3, a long non-coding RNA, is decreased in castration-resistant prostate cancer (CRPC). Its restoration suppresses tumor growth and migration, offering a potential therapeutic target for prostate cancer (PCa).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer (PCa) is a prevalent malignancy in elderly males, with castration-resistant prostate cancer (CRPC) posing significant therapeutic challenges.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development and drug resistance, highlighting their clinical significance.

Purpose of the Study:

  • To investigate the role of MAGI2 Antisense RNA 3 (MAGI2-AS3) in prostate cancer progression and its potential as a therapeutic target.
  • To analyze the diagnostic and prognostic value of MAGI2-AS3 in CRPC using bioinformatics and clinical specimens.

Main Methods:

  • RNA-sequencing datasets were used to determine gene expression in prostate tissues.
  • Bioinformatic analyses were performed to assess the diagnostic and prognostic values of CRPC-associated genes.
  • The expression, clinical significance, and functional activity of MAGI2-AS3 were evaluated in PCa cell lines and animal xenograft models.

Main Results:

  • MAGI2-AS3 expression was significantly decreased in CRPC and negatively correlated with Gleason score and lymph node status.
  • Low MAGI2-AS3 expression was associated with poorer patient survival.
  • Overexpression of MAGI2-AS3 inhibited PCa cell proliferation and migration in vitro and in vivo, potentially via a miR-106a-5p/RAB31 pathway.

Conclusions:

  • MAGI2-AS3 acts as a tumor suppressor in CRPC.
  • MAGI2-AS3 represents a potential biomarker for prognosis and a therapeutic target for prostate cancer treatment.
Keywords:
MAGI2-AS3Prostate cancerRAB31miR-106a-5p

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.2K